Medical Staff Poster Session

[MSP-03] Medical Staff Poster Session 03

Fri. May 20, 2022 4:00 PM - 5:15 PM Poster (Tokyo International Forum E Block B2F Hall E)

Chair:Chigusa Watanabe(Hiroshima-Nishi Medical Center)

+Add all to schedule

[MSP-03-1] Task sharing between physicians and pharmacists to improve the quality and safety in stroke patients

^○Ryohei Suzuki^1,2, Takako Uchiya¹, Takamasa Sakai², Masaaki Takahashi¹, Masakuni Kenjo³, Ikuko Aiba³, Satoshi Okuda³, Fumiko Ohtsu² (1.Department of pharmacy, National Hospital Organization Higashinagoya National Hospital, Japan, 2.Drug Informatics, Faculty of Pharmacy, Meijo University, Japan, 3.Department of Neurology, National Hospital Organization Higashinagoya National Hospital)

[MSP-03-2] The effectiveness of pharmacist intervention in outpatients with progressive Parkinson's disease

^○Kyohei Yamamoto, Mizuka Nagasaki, Yoshie Teramura, Akemi Oku, Kazuhisa Sawada, Ai Ohno, Yoji Sugiura (Department of Pharmacy Anjo Kosei Hospital, Japan)

[MSP-03-3] Usefulness of estimated GFR from cystatin C as a predictor of blood level of levetiracetam

^○Wataru Kobayashi¹, Yukihisa Yuzawa¹, Kenta Koike¹, Sayaka Yonekawa¹, Yuki Arai¹, Marie Takaura¹, Noriaki Natsume¹, Hidehiro Yonekawa¹, Momo Tani² (1.Department of Pharmacy, Seikeikai Sousen Hospital, Japan, 2.Department of Neurology, Seikeikai Sousen Hospital)

[MSP-03-4] A Study on the Pharmaceutical Care for Patients with Intractable Neuromascular Disease - Pilot Study

^○Hiroto Suzuki¹, Kasumi Abe², Kaname Tsuruga², Takashi Tokashiki³, Kyouichi Tumagari¹, Shin-ichi Yamagata⁴ (1.Division of Pharmaceutical Services, National Hospital Organization Okinawa National Hospital, Japan, 2.Division of Nursing, National Hospital Organization Okinawa National Hospital, 3.Division of Neurology, National Hospital Organization Okinawa National Hospital, 4.Division of Pharmaceutical Services , National Hospital Organization Kagoshima National Center)

[MSP-03-5] Factors associated with drooling in intractable neuromuscular disease and cerebral palsy patients

^○Natsuko Ishida¹, Shunsuke Ohno¹, Yoshitaka Ohshima¹, Ryohei Suzuki², Kei Nojiri^3,4, Shinnosuke Ootsuki⁵, Nobuyuki Zakoji³ (1.Faculty of Pharmacy, Institute of Medical, Pharmaceutical & Health Science, Kanazawa University, Japan, 2.Department of Pharmacy, National Hospital Organization Higashinagoya National Hospital, 3.Department of Pharmacy, National Hospital Organization Shizuoka Medical Center, 4.Department of Pharmacy, National Hospital Organization Suzuka Hospital, 5.Department of Pharmacy, Hokuriku Brain and Neuromuscular Disease Center, National Hospital Organization Iou Hospital)